|
91
|
290
|
3tjcA |
Co-crystal structure of jak2 with thienopyridine 8 |
|
31
|
98
|
3t04A |
Crystal structure of monobody 7c12/abl1 sh2 domain complex |
|
87
|
264
|
3sxrA |
Crystal structure of bmx non-receptor tyrosine kinase complex with dasatinib |
|
86
|
264
|
3sxsA |
Crystal structure of bmx non-receptor tyrosine kinase complexed with pp2 |
|
85
|
271
|
3srvA |
Crystal structure of spleen tyrosine kinase (syk) in complex with a diaminopyrimidine carboxamide inhibitor |
|
80
|
269
|
3srvB |
Crystal structure of spleen tyrosine kinase (syk) in complex with a diaminopyrimidine carboxamide inhibitor |
|
58
|
141
|
3s9oA |
The focal adhesion targeting (fat) domain of the focal adhesion kinase showing n-terminal interactions in cis |
|
88
|
292
|
3rvgA |
Crystals structure of jak2 with a 1-amino-5h-pyrido[4,3-b]indol-4-carboxamide inhibitor |
|
12
|
60
|
3rbbB |
Hiv-1 nef protein in complex with engineered hck sh3 domain |
|
11
|
60
|
3reaB |
Hiv-1 nef protein in complex with engineered hck-sh3 domain |
|
13
|
59
|
3rebB |
Hiv-1 nef protein in complex with engineered hck-sh3 domain |
|
76
|
275
|
5xp5A |
C-src in complex with atp-chf |
|
83
|
277
|
5xp7A |
C-src in complex with atp-chcl |
|
91
|
301
|
5wo4A |
Jak1 complexed with compound 28 |
|
76
|
274
|
5winA |
Jak2 pseudokinase in complex with jnj7706621 |
|
80
|
274
|
5wimA |
Jak2 pseudokinase in complex with at9283 |
|
81
|
285
|
5w86A |
Crystal structure of jak3 kinase domain with a 4,6-diaminonicotinamide inhibitor (compound number 7) |
|
92
|
298
|
5wevA |
Identification of an imidazopyridine scaffold to generate potent and selective tyk2 inhibitors that demonstrate activity in an in vivo psoriasis model |
|
69
|
302
|
5w5jA |
Identification of potent and selective ripk2 inhibitors for the treatment of inflammatory diseases |
|
97
|
288
|
5walA |
Identification of an imidazopyridine scaffold to generate potent and selective tyk2 inhibitors that demonstrate activity in an in vivo psoriasis model |
|
89
|
285
|
5vo6A |
Crystal structure of jak3 kinase domain in complex with a pyrrolopyridazine inhibitor |
|
79
|
279
|
5vc6A |
Crystal structure of human wee1 kinase domain in complex with pha-848125 |
|
79
|
279
|
5vc4A |
Crystal structure of human wee1 kinase domain in complex with bosutinib-isomer |
|
79
|
277
|
5vd2A |
Crystal structure of human wee1 kinase domain in complex with pf-03814735 |
|
79
|
279
|
5vd5A |
Crystal structure of human wee1 kinase domain in complex with rac-iv-050, a mk1775 analougue |
|
73
|
279
|
5vd8A |
Crystal structure of human wee1 kinase domain in complex with rac-iv-099, a mk1775 analogue |
|
108
|
460
|
5ve6A |
Crystal structure of sugen kinase 223 |
|
79
|
279
|
5vc5A |
Crystal structure of human wee1 kinase domain in complex with pd-166285 |
|
77
|
279
|
5vdaA |
Crystal structure of human wee1 kinase domain in complex with rac-iv-101, a mk1775 analogue |
|
78
|
279
|
5vd4A |
Crystal structure of human wee1 kinase domain in complex with rac-iv-016, a mk1775 analougue |
|
80
|
280
|
5vd9A |
Crystal structure of human wee1 kinase domain in complex with rac-iv-097, a mk1775 analogue |
|
79
|
277
|
5v5yA |
Crystal structure of human wee1 kinase domain in complex with mk1775 |
|
91
|
265
|
5vgoA |
Bruton's tyrosine kinase (btk) with compound g-744 |
|
76
|
283
|
5vdkA |
Crystal structure of human wee2 kinase domain in complex with mk1775 |
|
75
|
279
|
5vd7A |
Crystal structure of human wee1 kinase domain in complex with rac-iv-098, a mk1775 analogue |
|
86
|
272
|
5uszA |
Jak2 jh2 in complex with jnj-7706621 |
|
81
|
272
|
5ut3A |
Jak2 jh2 in complex with ikk-2 inhibitor vi |
|
83
|
272
|
5ut0A |
Jak2 jh2 in complex with at9283 |
|
86
|
272
|
5ut5A |
Jak2 jh2 in complex with glpg0634 |
|
85
|
272
|
5ut1A |
Jak2 jh2 in complex with bi-d1870 |
|
83
|
273
|
5ut4A |
Jak2 jh2 in complex with nvp-bsk805 |
|
83
|
273
|
5ut2A |
Jak2 jh2 in complex with prt062607 |
|
85
|
272
|
5ut6A |
Jak2 jh2 in complex with a diaminopyrimidine |
|
95
|
291
|
5usyA |
Jak2 jh1 in complex with jnj-7706621 |
|
100
|
271
|
5u9dA |
Discovery of a potent btk inhibitor with a novel binding mode using parallel selections with a dna-encoded chemical library |
|
98
|
333
|
5twzA |
Structure of maternal embryonic leucine zipper kinase |
|
88
|
336
|
5tx3A |
Structure of maternal embryonic leucine zipper kinase |
|
106
|
336
|
5twuA |
Structure of maternal embryonic leucine zipper kinase |
|
89
|
290
|
5tq3A |
Design and synthesis of a pan-jak kinase inhibitor clinical candidate (pf-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin |
|
92
|
282
|
5tt7A |
Discovery of tak-659, an orally available investigational inhibitor of spleen tyrosine kinase (syk) |
